SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 121 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is 0.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $39,000 | +875.0% | 1,000 | +233.3% | 0.03% | +1000.0% |
| Q1 2015 | $4,000 | -42.9% | 300 | -40.0% | 0.00% | -40.0% |
| Q4 2014 | $7,000 | -92.1% | 500 | -88.1% | 0.01% | -90.0% |
| Q3 2014 | $89,000 | +20.3% | 4,200 | +68.0% | 0.05% | +22.0% |
| Q2 2014 | $74,000 | +208.3% | 2,500 | +150.0% | 0.04% | +156.2% |
| Q1 2014 | $24,000 | -22.6% | 1,000 | -33.3% | 0.02% | -11.1% |
| Q4 2013 | $31,000 | -34.0% | 1,500 | +50.0% | 0.02% | -35.7% |
| Q3 2013 | $47,000 | -17.5% | 1,000 | -33.3% | 0.03% | -30.0% |
| Q2 2013 | $57,000 | – | 1,500 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |